Skip to content

Vocal in Assessment of Endometrium in Postmenopause

The Relation Between Endometrial Volume by 3D Vocal Ultrasound and Histopathology in Women With Postmenopausal Bleeding

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03404154
Enrollment
150
Registered
2018-01-19
Start date
2018-01-18
Completion date
2018-08-25
Last updated
2018-10-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postmenopausal Bleeding

Brief summary

The unbalanced estrogen with no progesterone will lead to endometrial thickening .This thickening result in endometrial hyperplasia & carcinoma and lead to irregular bleeding

Detailed description

Recent advances in the screening and diagnosis of endometrial pathologies (eg,endometrial hyperplasia , endometrial carcinoma ,endometrial polyps and myomas ) are directed towards non invasive methods as Transvaginal ultrasound with 3 D application using different softwares . One of the applications of 3D Transvaginal Ultrasonography is Vocal technique ( Virtual Organ Computer aided Analysis ) that can measure volume especially in tissues with irregular borders And this technology is considered to be superior than the conventional 2 D ultrasound . .

Interventions

DIAGNOSTIC_TEST3D ultrasound

it describes the diagnostic test which is 3D us to diagnose the cause of postmenopausal bleeding

PROCEDUREDilatation and curretage

it describes the surgical maneuver that will be made to diagnose cause of bleeding

Sponsors

Kasr El Aini Hospital
CollaboratorOTHER
om almasreen hospital ,Egypt
CollaboratorUNKNOWN
National Research Centre, Egypt
CollaboratorOTHER
Aljazeera Hospital
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
FEMALE
Age
50 Years to 80 Years
Healthy volunteers
Yes

Inclusion criteria

-Postmenopausal women who were Complaining of Post-menopausal vaginal bleeding.

Exclusion criteria

* Women with hormone replacement therapy. * Women showing intra-cavitary fluid collection at ultrasound examination * Women with other gynecological lesions in the pelvis other than the uterus * Previous diagnosis of endometrial pathology.

Design outcomes

Primary

MeasureTime frameDescription
the number of participants who where diagnosed by 3D vocal to have endometrial carcinomawithin 4 weeksit describes how many women will be properly diagnosed with carcinoma

Countries

Egypt

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026